Vivo Capital »

Precision Biosciences shares owned by Vivo Capital

Quarter-by-quarter ownership of Precision Biosciences (DTIL) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Precision Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Precision Biosciences held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precision Biosciences by Vivo Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $63k 4.7k 13.56

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Geron Corp Common (GERN)
Harmony Biosciences Holdings Common (HRMY)
Sinovac Biotech SHS (SVA)
Avadel Pharmaceuticals Adr
Verona Pharma Sponsored Ads (VRNA)
ALX Oncology Holdings Common (ALXO)
Dyne Therapeutics Common (DYN)
Terns Pharmaceuticals Common (TERN)
Astria Therapeutics Common (ATXS)
Viridian Therapeutics Common (VRDN)
Silence Therapeutics Ads (SLN)
Olema Pharmaceuticals Common (OLMA)
Adverum Biotechnologies Common (ADVM)
Alpine Immune Sciences Common

View all positions for Vivo Capital

Top funds holding Precision Biosciences

Henderson Group
Tang Capital Management
Perceptive Advisors
Aquilo Capital Management
Vanguard Group
Alyeska Investment Group
Acadian Asset Management
Citadel Advisors
Renaissance Technologies
Geode Capital Management
BlackRock
BlackRock
Northern Trust
Royal Bank of Canada
Moloney Securities Asset Management

View all funds holding Precision Biosciences